Drug intelligence / Profile preview

ketoconazole + zinc pyrithione

Development stage
Phase 4
Lead developer
Biogracea Medicare
Modality
Small Molecules
Administration
Topical
01

Overview

Ketoconazole + zinc pyrithione is a topical combination therapy developed by Biogracea Medicare for the treatment of fungal skin infections and scalp conditions such as seborrheic dermatitis and dandruff. Ketoconazole, an imidazole derivative, exerts its antifungal effect by inhibiting the enzyme lanosterol 14-alpha demethylase, which is critical for the biosynthesis of ergosterol in fungal cell membranes. Zinc pyrithione is a coordination complex that possesses both antifungal and antibacterial properties; it is thought to work by disrupting membrane transport and cellular metabolism, potentially through the regulation of intracellular metal ion concentrations. This synergistic combination is typically delivered in a shampoo or lotion base, providing both rapid symptomatic relief and long-term control of Malassezia-related conditions.

Brand names
KETO-Z
Other names
ketoconazole and zinc pyrithione
02

Targets

CYP51A1 (Sterol 14α-demethylase)Mitochondrial iron–sulfur cluster assembly machineryUCHL5 (Ubiquitin carboxyl-terminal hydrolase isozyme L5)

Beyond the preview

Go deeper on ketoconazole + zinc pyrithione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketoconazole + zinc pyrithione.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call